Switch to:
Nivalis Therapeutics Inc (NAS:NVLS)
Cash Flow for Capital Expenditures
$-0.00 Mil (TTM As of Mar. 2015)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Nivalis Therapeutics Inc's cash flow for capital expenditures for the six months ended in Mar. 2015 was $-0.05 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.00 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nivalis Therapeutics Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Nivalis Therapeutics Inc Annual Data

Dec12Dec13Dec14
Cash Flow_CPEX 0.000.000.000.000.000.000.00-0.03-0.13-0.00

Nivalis Therapeutics Inc Semi-Annual Data

Dec12Dec13Mar14Dec14Mar15
Cash Flow_CPEX 0.000.000.000.000.00-0.03-0.13-0.00-0.00-0.05
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK